PSORIASIS VULGARIS
Clinical trials for PSORIASIS VULGARIS explained in plain language.
Never miss a new study
Get alerted when new PSORIASIS VULGARIS trials appear
Sign up with your email to follow new studies for PSORIASIS VULGARIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Higher brodalumab dose shows promise for heavier psoriasis patients
Disease control CompletedThis study looked at whether a higher dose of the drug brodalumab works better than the standard dose for people with moderate-to-severe plaque psoriasis who weigh over 120 kg. A total of 385 adults took part. The main goal was to see if more people achieved at least 90% clearer …
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: LEO Pharma • Aim: Disease control
Last updated May 26, 2026 07:04 UTC
-
Light-Activated gel shows promise for psoriasis in early trial
Disease control CompletedThis study tested a gel called SGX302 (synthetic hypericin) combined with visible light to treat mild-to-moderate psoriasis. Fifteen adults with plaque psoriasis applied the gel to their skin and received light therapy over 18 weeks. The goal was to see if the treatment could cle…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Soligenix • Aim: Disease control
Last updated May 26, 2026 07:04 UTC
-
Psoriasis patients may cut biologic doses without Flare-Ups
Disease control CompletedThis study tested whether psoriasis patients with well-controlled disease can safely reduce their dose of IL17 or IL23 inhibitor biologics without causing flare-ups. 244 adults with stable psoriasis (clear or almost clear skin for at least 6 months) were randomly assigned to eith…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE4 • Sponsor: Radboud University Medical Center • Aim: Disease control
Last updated May 20, 2026 11:56 UTC
-
Could a plant cream soothe psoriasis? new trial tests natural remedy
Symptom relief CompletedThis study tested a cream made from plant compounds (total coumarins) in 88 adults with mild-to-moderate psoriasis. Participants applied the cream or a placebo for several weeks. The goal was to see if the cream could reduce skin redness, scaling, and thickness better than a plac…
Matched conditions: PSORIASIS VULGARIS
Phase: PHASE2 • Sponsor: Psoriasis Research Institute of Guangzhou • Aim: Symptom relief
Last updated May 26, 2026 07:04 UTC